Evonik names IMCD as European distributor of its Medical Care series in European Economic Area countries; collaboration expands polymer opportunities in applications such as medical tubing, dialyzer parts, surgical instruments, inhalers

IMCD, a global leader in the distribution of specialty chemicals and ingredients has entered into a strategic distribution agreement with Evonik, a specialty chemicals company. Under this agreement, IMCD will serve as Evonik's European distributor for its Medical Care series, covering EEA countries including the United Kingdom and Switzerland . This partnership represents a step forward for IMCD in expanding its presence in the market segment of medical devices. Taken effect on 1 May 2023 , this agreement will enable Evonik to expand its reach and to better serve its customers.

As a distributor with a strong presence in medical and healthcare applications, IMCD offers a dedicated medical application team, which makes the company an ideal partner for Evonik's European customers. Expanding the IMCD medical polymer portfolio with Evonik's Medical Care Series will create synergies that offer new opportunities for medical industry customers in various applications like medical tubing, dialyzer parts, surgical instruments, and inhalers.

"We are confident that this partnership with IMCD will enable us to address the evolving requirements in the medical sector," said Dr. Philip Engel , Head of Medical Systems Europe at Evonik, "IMCD brings extensive market knowledge and technical expertise that we can rely on to meet the needs of our customers in order to accelerate further business growth."

Jana Zietzling, Head of Product Management Medical at IMCD Business Group Advanced Materials, "We are excited to partner with Evonik and add their high-performance polymers to our portfolio. By leveraging our shared commitment to innovation and our in-depth knowledge in medical polymer and applications, we are able to support customers even better in their product development of medical devices."
For further questions, please contact our Media Relations Team